Akamai Technologies heads into its May 13 Q1 results having just delivered one of the most violent short-covering rallies in its recent history.
The stock exploded 27% on May 8 — off a Q4 earnings beat released the prior evening — and added another 42% on the week. That move landed the stock at $147.71, back within touching distance of the mean analyst price target of $147.97. Short sellers holding 12% of the free float woke up on the wrong side of that trade. Short interest had been climbing through April, peaking above 18 million shares around mid-month before pulling back modestly to 17.2 million by May 7. That is still roughly 9% above where it stood six weeks ago. The borrow market, however, has not tightened to reflect this stress: cost to borrow eased to 0.48% after falling almost 9% on the week, a signal that lenders are not scrambling and availability remains comfortable. Short sellers are underwater but not yet squeezed.
The analyst community reacted immediately and in force. Seven firms raised their price targets on May 8 alone — all maintaining their prior ratings rather than upgrading. Evercore ISI lifted from $130 to $165, Guggenheim moved from $133 to $181, and Keybanc went furthest at $195 from $120. The mass of targets now clusters in the $150–$195 range, straddling the current price after the post-earnings move repriced the stock from the low $100s. The ratings themselves tell the debate more honestly than the targets do: bulls (Guggenheim Buy, Evercore Outperform, Keybanc Overweight) argue the Edgio acquisition and expanding cloud and AI partnerships position Akamai for re-accelerating growth. Bears (UBS, Piper Sandler, RBC all at Neutral) see a CDN franchise under structural pressure as hyperscaler competition intensifies and cloud infrastructure investments weigh on near-term earnings power. Baird, notably, downgraded to Neutral on April 2 — before the squeeze — and has not publicly reversed.
The institutional ownership picture adds a wrinkle. First Trust Advisors added 957,000 shares in the most recent reporting period, one of the larger incremental additions in the holder table. BNY Asset Management added over 820,000. Dimensional Fund Advisors added 784,000. These are not passive-index flows; they reflect active positioning into what was, until last week, a beaten-down name. The flip side is that insider activity through March was exclusively sales — CFO Edward McGowan, the COO, the General Counsel, and senior VPs all sold at prices between $101 and $108, now well below the current level. That selling cluster below $110 does not invalidate the bull case, but it does complicate it.
The May 13 print is less about whether Akamai is growing and more about whether management can offer Q2 guidance that justifies a stock now trading at 21x earnings and a P/B that has re-rated sharply on a single day's move — positioning that, with shorts still at 12% of the float and options PCR only mildly above its 20-day average, looks charged but not yet fully resolved.
See the live data behind this article on ORTEX.
Open AKAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
Akamai Technologies heads into its May 7 Q1 results with short sellers reducing exposure even as the stock endures its worst month in recent memory. The most striking tension in the data right now is this: shorts have…
